Compass Therapeutics clinical trials we track

Check company identity source

Phase 2 / 3 1 trial

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
A Study of CTX-009 in Adult Patients With Metastatic Colorectal CancerNCT05513742CTX-009Completed2025-05-15Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Best Overall Response Description: Percentage of patients whose Best Overall Response (BOR) is assessed as Complete Response (CR) or Partial Response (PR) as assessed by RECIST 1.1 Time frame: From randomization to treatment discontinuation for any reason, average 6 months. After: Measure: Best Overall Response Description: Percentage of patients whose Best Overall Response (BOR) is assessed as Complete Response (CR) or Partial Response (PR). Per Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.0) for target lesions and assessed by CT or MRI: CR: disappearance of all target lesions; PR: \>=30% decrease in the sum of the longest diameter of target lesions. Time frame: From randomization to treatment discontinuation for any reason, average 6 months.

Check registry source

· 3 fields changed

Completion date type changed

Before: Actual. After: Estimated.

Primary completion date changed

Before: 21 Jan 2026. After: 1 Dec 2026.

Recruitment status changed

Before: Completed. After: Active not recruiting.

Check registry source

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 150 participants (planned). After: 168 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Jul 2025. After: 21 Jan 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source